Paper41990751
Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transition.
Reyes J and 24 others. Cell, 2026. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transition. Papers, record 41990751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41990751
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transition.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Pancreatic Ductal | Major topic |
| Pancreatic Neoplasms | Major topic |
| Stem Cell Niche | Major topic |
| Animals | |
| Mice | |
| Tumor Suppressor Protein p53 | |
| Cyclin-Dependent Kinase Inhibitor p16 | |
| Proto-Oncogene Proteins p21(ras) | |
| Smad4 Protein | |
| Neoplastic Stem Cells | |
| Humans | |
| Epithelial-Mesenchymal Transition |
Source PubMed
Grants16
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| F31 CA290899 | NCI NIH HHS | United States | F31CA290899 | PubMed | NIH RePORTER |
| U54 CA274492 | NCI NIH HHS | United States | U54CA274492 | PubMed | NIH RePORTER |
| U54 CA274371 | NCI NIH HHS | United States | U54CA274371 | PubMed | NIH RePORTER |
| P01 CA291694 | NCI NIH HHS | United States | P01CA291694 | PubMed | NIH RePORTER |
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed | NIH RePORTER |
| R01 CA260752 | NCI NIH HHS | United States | R01CA260752 | PubMed | NIH RePORTER |
| K00 CA245471 | NCI NIH HHS | United States | K00CA245471 | PubMed | NIH RePORTER |
| P30 CA045508 | NCI NIH HHS | United States | P30CA045508 | PubMed | NIH RePORTER |
| U01 CA224145 | NCI NIH HHS | United States | U01CA224145 | PubMed | NIH RePORTER |
| R01 CA264843 | NCI NIH HHS | United States | R01CA264843 | PubMed | NIH RePORTER |
| K08 CA255574 | NCI NIH HHS | United States | K08CA255574 | PubMed | NIH RePORTER |
| U01 CA274154 | NCI NIH HHS | United States | U01CA274154 | PubMed | NIH RePORTER |
| R01 CA271510 | NCI NIH HHS | United States | R01CA271510 | PubMed | NIH RePORTER |
| R01 CA283378 | NCI NIH HHS | United States | R01CA283378 | PubMed | NIH RePORTER |
| R37 CA304010 | NCI NIH HHS | United States | R37CA304010 | PubMed | NIH RePORTER |
| R01 CA268426 | NCI NIH HHS | United States | R01CA268426 | PubMed | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 40,661,354 | Oncogenic and tumor-suppressive forces converge on a progenitor-orchestrated niche to shape early tumorigenesis. | https://conductscience.org/library/papers/40661354 |
Source PubMed
References159
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26,002,886 | Diffusion maps for high-dimensional single-cell analysis of differentiation data. | Bioinformatics | 2015 | https://conductscience.org/library/papers/26002886 | PubMed |
| 2 | 29,961,579 | Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment. | Cell | 2018 | https://conductscience.org/library/papers/29961579 | PubMed |
| 3 | 16,601,750 | The complexity of p53 stabilization and activation. | Cell Death Differ | 2006 | https://conductscience.org/library/papers/16601750 | PubMed |
| 4 | 1,588,974 | A transcriptionally active DNA-binding site for human p53 protein complexes. | Mol Cell Biol | 1992 | https://conductscience.org/library/papers/1588974 | PubMed |
| 5 | 39,112,713 | Titration of RAS alters senescent state and influences tumour initiation. | Nature | 2024 | https://conductscience.org/library/papers/39112713 | PubMed |
| 6 | 29,099,489 | Deconstructing networks of p53-mediated tumor suppression in vivo. | Cell Death Differ | 2018 | https://conductscience.org/library/papers/29099489 | PubMed |
| 7 | 36,302,222 | Senescence Rewires Microenvironment Sensing to Facilitate Antitumor Immunity. | Cancer Discov | 2023 | https://conductscience.org/library/papers/36302222 | PubMed |
| 8 | 27,585,860 | Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers. | Nat Commun | 2016 | https://conductscience.org/library/papers/27585860 | PubMed |
| 9 | 19,668,189 | A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. | Nature | 2009 | https://conductscience.org/library/papers/19668189 | PubMed |
| 10 | 36,450,983 | Ras drives malignancy through stem cell crosstalk with the microenvironment. | Nature | 2022 | https://conductscience.org/library/papers/36450983 | PubMed |
| 11 | 38,831,382 | Role of cellular senescence in inflammation and regeneration. | Inflamm Regen | 2024 | https://conductscience.org/library/papers/38831382 | PubMed |
| 12 | 33,633,365 | ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. | Nat Genet | 2021 | https://conductscience.org/library/papers/33633365 | PubMed |
| 13 | 17,360,542 | The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17360542 | PubMed |
| 14 | 25,858,977 | RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells. | Science | 2015 | https://conductscience.org/library/papers/25858977 | PubMed |
| 15 | 41,916,312 | A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy. | Cell | 2026 | https://conductscience.org/library/papers/41916312 | PubMed |
| 16 | 24,766,814 | Single-cell trajectory detection uncovers progression and regulatory coordination in human B cell development. | Cell | 2014 | https://conductscience.org/library/papers/24766814 | PubMed |
| 17 | 36,727,849 | Arginase 1 is a key driver of immune suppression in pancreatic cancer. | Elife | 2023 | https://conductscience.org/library/papers/36727849 | PubMed |
| 18 | 35,859,028 | The emerging landscape of spatial profiling technologies. | Nat Rev Genet | 2022 | https://conductscience.org/library/papers/35859028 | PubMed |
| 19 | 38,683,144 | Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer. | Cancer Discov | 2024 | https://conductscience.org/library/papers/38683144 | PubMed |
| 20 | 9,054,499 | Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. | Cell | 1997 | https://conductscience.org/library/papers/9054499 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,535,370 | Unveiling the role of spatial transcriptomics in the analysis of the tumor immune microenvironment (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42535370 | PubMed |
| 42,523,238 | The basal cell state maintains pancreatic cancers by controlling an immunosuppressive circuit. | bioRxiv | 2026 | https://conductscience.org/library/papers/42523238 | PubMed |
| 42,244,674 | GATA4 loss promotes mutant Kras-driven pancreatic ductal adenocarcinoma in the absence of canonical precursor lesions. | bioRxiv | 2026 | https://conductscience.org/library/papers/42244674 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41990751
GET https://conductscience.org/api/papers/v1/41990751/authors?page=2